A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold. According to our (Global Info Research) latest study, the global Generic Drugs market size was valued at USD 322540 million in 2022 and is forecast to a readjusted size of USD 550750 million by 2029 with a CAGR of 7.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. Market competition is not intense. Teva, Novartis ﾖ Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares. North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%. This report is a detailed and comprehensive analysis for global Generic Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Generic Drugs market size and forecasts, in consumption value ($ Million), 2018-2029 Global Generic Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Generic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Generic Drugs market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Generic Drugs To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Generic Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical and Aspen, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Generic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Prescription Non-Prescription Drugs Market segment by Application Hospital Clinic Others Market segment by players, this report covers Teva Novartis - Sandoz Mylan Sun Pharmaceutical Aspen Fresenius Kabi Pfizer (Hospira) Sanofi Aurobindo Lupin Dr. Reddy's Apotex Cipla ENDO (Par Pharmaceutical) Stada Arzneimittel Krka Group Nichi-Iko Pharmaceutical Valeant Zydus Cadila Hikma Pharmaniaga Berhad Hovid Berhad Duopharma Biotech Kotra Pharma HOE Pharmaceutical Y.S.P. Industries Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Generic Drugs product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Generic Drugs, with revenue, gross margin and global market share of Generic Drugs from 2018 to 2023. Chapter 3, the Generic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Generic Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Generic Drugs. Chapter 13, to describe Generic Drugs research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Generic Drugs 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Generic Drugs by Type 1.3.1 Overview: Global Generic Drugs Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Generic Drugs Consumption Value Market Share by Type in 2022 1.3.3 Prescription 1.3.4 Non-Prescription
